Rapid determination of haloperidol and its metabolites in human plasma by HPLC using monolithic silica column and solid‐phase extraction
- 31 October 2005
- journal article
- research article
- Published by Wiley in Biomedical Chromatography
- Vol. 20 (8) , 760-764
Abstract
A rapid, sensitive and reproducible HPLC method was developed and validated for the analysis of haloperidol and its three main metabolites in human plasma. The analysis was carried out on a monolithic silica column (Chromolith Performance RP‐18e, 100 × 4.6 mm). The mobile phase consisted of sodium phosphate (0.1 m, pH 3.5)–acetonitrile (80:20, v/v) at a flow rate of 2.0 mL/min. UV detection at 230 nm was used, with the detection limits of these compounds ranging from 2 to 5 ng. The separation factors of all studied compounds were in the range 2.30–16.32, while the resolution factors were from 1.00 to 5.37. Copyright © 2005 John Wiley & Sons, Ltd.Keywords
This publication has 6 references indexed in Scilit:
- Monolithic silica columns for high-efficiency chromatographic separationsJournal of Chromatography A, 2002
- Chromatographic silanol activity test procedures: the quest for a universal testJournal of Chromatography A, 2000
- Pharmacokinetics of HaloperidolClinical Pharmacokinetics, 1999
- Performance of an octadecylsilylated continuous porous silica column in polypeptide separationsJournal of Chromatography A, 1998
- Designing monolithic double-pore silica for high-speed liquid chromatographyJournal of Chromatography A, 1998
- High-performance liquid chromatographic method for the detection and quantitation of haloperidol and seven of its metabolites in microsomal preparationsJournal of Chromatography B: Biomedical Sciences and Applications, 1993